Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash PLC Regulatory News (KP2)

Share Price Information for Kore Potash PLC (KP2)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.20 (7.14%)
Bid:
2.90
Ask:
3.10
Spread: 0.20 (6.897%)
Market Cap: £155.28m
KP2 Live PriceLast checked at - London Stock Exchange

Intraday Kore Potash PLC Share Chart

Statement re. Suspension

1 May 2025 08:00

RNS Number : 0099H
Kore Potash PLC
01 May 2025
 

1 May 2025

 

KORE POTASH PLC

("Kore Potash" or "the Company")

Suspension of Trading

Draft non-binding financing Term-Sheet received

 

Kore Potash plc, the potash development company with 97% ownership of the Kola and DX Potash Projects in the Sintoukola Basin, located in the Republic of Congo, announces that further to the Company's request to the Australian Securities Exchange ("ASX") on 29 April 2025 to halt trading in the Company's securities quoted on the ASX to facilitate the review, negotiations and agreement of the draft financing proposal and associated draft non-binding Term Sheets ("Term Sheets") for the Kola Project, as received from the Summit Consortium ("Consortium") on 28 April 2025, the Company is unable to comply with the timeline imposed by the ASX in announcing details under the Term Sheets. The ASX is of the view that the Company received the Terms Sheets, details of which it should be able to announce. The Company is however not able to comply with this requirement at present given the nature and contents of the Term Sheet, and ongoing review and negotiation thereof.

 

As the Company is unable to comply with this requirement before market open on 1 May 2025, ASX imposed a suspension on trading ("Suspension") in the Company's quoted securities under ASX Listing Rule 17.3, with the Suspension remaining in place until the details, or otherwise, of the Term Sheets are announced. The Company notes that the Term Sheets allow a period up to 31 May 2025, unless otherwise agreed, to review, negotiate and agree formal terms.

 

The JSE Limited ("JSE") in accordance with their rules has indicated that the halt in trading ("Trading Halt") in the Company's shares quoted on the JSE will not continue and has subsequently ended. Shareholders on the JSE are advised that the full impact of the finalised, agreed and executed Term Sheets when concluded may have a material effect on the price of the Company's shares. Accordingly, shareholders on the JSE are advised to exercise caution when dealing in the Company's shares until full disclosure regarding the finalised, agreed and executed Term Sheets is made.

 

The Company's securities will accordingly not be traded on the ASX whilst the Suspension remains in place.

 

Trading in the Company's ordinary securities will continue to trade as normal on AIM, a market operated by the London Stock Exchange, and on the JSE during this period.

 

The full version of the ASX announcement can be seen here: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02942182-6A1262868&v=7bc42bd11d853ed5e8c28f2ffcd6a069ee5cd6b4

 

This announcement has been approved for release by the Board.

 

For further information, please visit www.korepotash.com or contact:

 

Kore Potash

Andre Baya, CEO

Andrey Maruta, CFO

Tel: +44 (0) 20 3963 1776

Tavistock Communications

Nick Elwes Emily Moss

 

 

Tel: +44 (0) 20 7920 3150

SP Angel Corporate Finance - Nomad and Broker

Ewan Leggat

Charlie Bouverat

Grant Barker

Tel: +44 (0) 20 7470 0470

Shore Capital - Joint Broker Toby Gibbs

James Thomas

Tel: +44 (0) 20 7408 4050

Questco Corporate Advisory - JSE Sponsor

Doné Hattingh

Tel: +27 (63) 482 3802

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SRSEAKSFEFSSEEA
Date   Source Headline
6th Dec 20247:00 amRNSCDI Monthly Movement
27th Nov 202410:49 amRNSResponse to ASX Aware Letter
22nd Nov 20247:00 amRNSLodgement of Cleansing Prospectus
20th Nov 20247:00 amRNSFinalisation of EPC Contract
11th Nov 20241:49 pmRNSTrading Halt, Amended Admission,Fundraising Update
7th Nov 20249:37 amRNSTrading Halt, & Amended Admission Date
5th Nov 202411:29 amRNSAnnouncement of Fundraise
5th Nov 20247:00 amRNSCDI Monthly Movement
31st Oct 20247:00 amRNSReview of Operations for Quarter to 30 Sept 2024
4th Oct 20247:00 amRNSCDI Monthly Movement
13th Sep 20247:00 amRNSFinancial Results for Half Year Ended 30 June 2024
4th Sep 20247:00 amRNSCDI Monthly Movement
23rd Aug 20242:00 pmRNSResults of General Meeting
6th Aug 20247:00 amRNSCDI Monthly Movement
31st Jul 20247:00 amRNSReview of Operations for Quarter to 30 June 2024
23rd Jul 20247:00 amRNSNotice of GM
3rd Jul 20247:00 amRNSCDI Monthly Movement
1st Jul 20249:30 amRNSFundraise of US$1,281,000
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
24th Jun 20249:15 amRNSEPC Update
6th Jun 202411:15 amRNSResult of AGM
5th Jun 20247:00 amRNSCDI Monthly Movement
4th Jun 20247:00 amRNSRemote Access to AGM
23rd May 202411:06 amRNSResponse to ASX price and volume query
14th May 20249:00 amRNSResults of General Meeting & Issue of Shares
14th May 20247:00 amRNSCommencement of Trading on A2X Exchange
8th May 20247:00 amRNSCDI Monthly Movement
7th May 20247:00 amRNSSecondary Listing on A2X Exchange
3rd May 20247:00 amRNSNotice of 2024 AGM
29th Apr 20247:00 amRNSReview of Operations - Quarter ended 31 March 2024
15th Apr 20247:00 amRNSPDMR Grant of Options
12th Apr 20247:00 amRNSNotice of General Meeting
5th Apr 20247:00 amRNSCDI Monthly Movement
4th Apr 20247:00 amRNSAppointment of CEO
28th Mar 20247:15 amRNSFundraise – CLN Conversion & Chair Participation
28th Mar 20247:02 amRNSFinancial Results for Year Ended 31 December 2023
22nd Mar 20247:00 amRNSFundraise of US$ 530,000
6th Mar 20247:00 amRNSCDI Monthly Movement
9th Feb 20247:00 amRNSEPC Update
6th Feb 20247:00 amRNSCDI Monthly Movement
18th Jan 20247:00 amRNSReview of Operations for quarter ended 31 Dec 2023
5th Jan 20247:00 amRNSCDI Monthly Movement
29th Dec 20237:00 amRNSTotal Voting Rights
21st Dec 202311:00 amRNSTR-1: Notification of major holdings
11th Dec 20237:00 amRNSManagement changes
7th Dec 20231:00 pmRNSResults of General Meeting
7th Dec 20237:00 amRNSCDI Monthly Movement
30th Nov 20237:00 amRNSTotal Voting Rights
6th Nov 20237:00 amRNSNotice of General Meeting
3rd Nov 20237:05 amRNSCDI Monthly Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.